Prof. Dr. Nesrin KARAMUSTAFALIOĞLU

1. Changes in serum Nogo-A and BDNF levels following treatment in drug-naive first-episode schizophrenia: A naturalistic prospective study

Dudaklı B. B., Uzel H. K., Ocak M. S., Esen Öksüzoğlu M., Levent Çıraklı Z., KARAMUSTAFALIOĞLU N.

Psychiatry Research , cilt.361, 2026 (SCI-Expanded, SSCI, Scopus)

2. The Bipolar Disorder Medication Adherence Battery: validity, reliability, and clinical benchmarks

Ünver B., Sertel Berk Ö., KARAMUSTAFALIOĞLU N.

Frontiers in Psychiatry , cilt.16, 2026 (SCI-Expanded, SSCI, Scopus)

3. Binge Eating Disorder in Bipolar I Disorder: Prevalence, Childhood Trauma, and Clinical Correlates

Karabiyik B., Onur Ö. Ş., KARAMUSTAFALIOĞLU N.

Noropsikiyatri Arsivi , cilt.63, ss.380-386, 2026 (SCI-Expanded, Scopus, TRDizin)

4. Suicide in Bipolar Disorder: The Role of Emotional Dysregulation, Childhood Trauma and Resilience Bipolar Bozuklukta İntihar: Duygu Düzenleme Güçlüğü, Çocukluk Çağı Travması ve Dayanıklılığın Rolü

Subaş E., Onur Ö. Ş., KARAMUSTAFALIOĞLU N.

Noropsikiyatri Arsivi , cilt.63, ss.57-64, 2026 (SCI-Expanded, Scopus, TRDizin)

5. The Role of Amphiregulin and Epidermal Growth Factor Receptor in First-Episode Psychosis: Exploring Links to Schizophrenia Pathophysiology

Güney Taşdemir B., Yeşilkaya Ü. H., Çirakli Z., KARAMUSTAFALIOĞLU N.

Noropsikiyatri Arsivi , cilt.63, ss.35-40, 2026 (SCI-Expanded, Scopus, TRDizin)

6. The effect of impoverishment of thought in early psychosis: Influence on suicide risk via depression and aggression

Celikkiran Erdem P., Gica S., PİRİ ÇİNAR B., KARAMUSTAFALIOĞLU N.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.38, sa.3, ss.136-147, 2025 (ESCI, Scopus, TRDizin)

7. Altered Volumes of the Amygdala and Hippocampus in the Brain of Suicidal Patients with First Episode Schizophrenia

Sen M., KARAMUSTAFALIOĞLU N., Celikkiran P., Ansen G., ŞAKUL B. U., NAMLI M. N., et al.

Psychiatric Quarterly , cilt.96, sa.2, ss.305-319, 2025 (SSCI, Scopus)

8. The Role of Resolvin D1 in Indicating Chronic Inflammation and Axonal Damage in Bipolar Disorder: A Comparative Study of Manic and Depressive Episodes Bipolar Bozuklukta Resolvin D1’in Kronik İnflamasyon ve Aksonal Hasarı Göstermedeki Rolü: Manik ve Depresif Epizodların Karşılaştırmalı Bir Çalışması

Kök Kendirlioğlu B., Yüksel Öksüz Ö., Kalelioğlu T., Sözen Ş., Ünalan Özperçin P., Cihnioğlu R., et al.

Noropsikiyatri Arsivi , cilt.62, sa.1, ss.3-10, 2025 (SCI-Expanded, Scopus, TRDizin)

9. Assessment of Malingering and Clinical Characteristics Among Arrested Offenders by Profiling Psychopathic Traits

Carpar E., BALABAN Ö. D., KARAMUSTAFALIOĞLU N.

Journal of Forensic Psychology Research and Practice , 2025 (SSCI, Scopus)

10. Evaluation of the Correlation Between Peripheral Inflammatory Markers and Suicide Risk in Drug-Naive First-Episode Schizophrenia İlaçsız İlk Epizot Şizofreni Hastalarında Periferik İnflamatuvar Belirteçler ile İntihar Riski Arasındaki İlişkinin Değerlendirilmesi

Yeşilkaya Ü. H., Şen M., Balcioğlu Y. H., Gökçay H., Çelikkiran P., Kirlioğlu Balcioğlu S., et al.

Noropsikiyatri Arsivi , cilt.61, sa.3, ss.275-280, 2024 (SCI-Expanded, Scopus, TRDizin)

11. High Mobility Group Box 1 Levels as an Inflammatory Mediator in Bipolar Mania Bipolar Manide Enflamasyon Belirteci Olarak High Mobility Grup 1 Protein

Kara A., BALABAN Ö. D., PİRİ ÇİNAR B., Tanriverdi Oluğ S., Kiliç C., KARAMUSTAFALIOĞLU N.

Noropsikiyatri Arsivi , cilt.61, sa.2, ss.160-166, 2024 (SCI-Expanded, Scopus, TRDizin)

12. Enlarged basal ganglia in drug-naïve patients with first-episode psychosis immediately upon symptom onset

Yesilkaya U. H., Sen M., YÜZBAŞIOĞLU N., Pence K. B., KARAMUSTAFALIOĞLU N.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.37, sa.1, ss.15-24, 2024 (ESCI, Scopus)

13. Eveningness chronotype influences social functioning by deteriorating depressive symptoms in remitted patients with schizophrenia

PİRİ ÇİNAR B., Gica Ş., Çelikkiran P., Kara A., Yeşilkaya U. H., KARAMUSTAFALIOĞLU N.

Chronobiology International , cilt.41, sa.6, ss.847-858, 2024 (SCI-Expanded, Scopus)

14. Investigating the effects of glucose and lipid metabolism on neuronal structure using optical coherence tomography in treatment-resistant schizophrenia

Yesilkaya U. H., Onur O. S., Acar O. P. A., Goy D. F., Onur I. U., KARAMUSTAFALIOĞLU N.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.36, sa.3, ss.157-167, 2023 (ESCI, Scopus, TRDizin)

15. The emotions experienced by family medicine residents and interns during their clinical trainings: A qualitative study

TANRIÖVER Ö., PEKER M. S., HIDIROĞLU S., KİTAPÇIOĞLU D., Inanici S. Y., KARAMUSTAFALIOĞLU N., et al.

Primary Health Care Research and Development , cilt.24, 2023 (SCI-Expanded, Scopus)

16. Can optical coherence tomography findings be related with suicide attempt in bipolar disorder?

Onur Ö. Ş., Yeşilkaya Ü. H., Subaş E., Açar Ö. P. A., Onur İ. U., KARAMUSTAFALIOĞLU N., et al.

Photodiagnosis and Photodynamic Therapy , cilt.41, 2023 (SCI-Expanded, Scopus)

17. Ten-Year Follow-Up of Earthquake Survivors: Long-Term Study on the Course of PTSD Following a Natural Disaster

KARAMUSTAFALIOĞLU K. O., Fostick L., Çevik M., Zukerman G., Tankaya O., Güveli M., et al.

Journal of Clinical Psychiatry , cilt.84, sa.2, 2023 (SCI-Expanded, SSCI, Scopus)

18. Detecting biomarkers associated with antipsychotic-induced extrapyramidal syndromes by using machine learning techniques

Kalelioglu T., KARAMUSTAFALIOĞLU N., Emul M., Celikel G., Ozonder İ., Kara A., et al.

Journal of Psychiatric Research , cilt.158, ss.300-304, 2023 (SCI-Expanded, SSCI, Scopus)

19. MAY PPAR GAMMA BE SIGNIFICANT IN BIPOLAR DISORDER ONLY IN THE PRESENCE OF METABOLIC SYNDROME?

Kendirlioglu B. K., Cihnioglu R., Kalelioglu T., Ozpercin P. U., Oksuz O. Y., Sozen S., et al.

Psychiatria Danubina , cilt.35, sa.2, ss.210-219, 2023 (SCI-Expanded, SSCI, Scopus) Sürdürülebilir Kalkınma

20. Can the Imbalance between Neurotrophic and Apoptotic Proteins Be the “Beware the Ides of March” for Unaffected Relatives of Schizophrenia Patients?

Yesilkaya U. H., Gica S., Menekseoglu P. O., Tasdemir B. G., Cirakli Z., KARAMUSTAFALIOĞLU N.

Molecular Neurobiology , cilt.59, sa.12, ss.7413-7422, 2022 (SCI-Expanded, Scopus)

21. Investigation of the effect of electroconvulsive treatment on serum glial cell line-derived neurotrophic factor levels in patients with schizophrenia and bipolar disorder

AKKUŞ M., Kalelioglu T., Kan H., KARAMUSTAFALIOĞLU N., Ilnem M. C.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.35, sa.2, ss.86-92, 2022 (ESCI, Scopus, TRDizin)

22. New variants and new symptoms in COVID-19: First episode psychosis and Cotard's Syndrome two months after infection with the B.1.1.7 variant of coronavirus

Yesilkaya U. H., Sen M., KARAMUSTAFALIOĞLU N.

Schizophrenia Research , cilt.243, ss.315-316, 2022 (SCI-Expanded, SSCI, Scopus)

23. A novel commentary: Investigation of the role of a balance between neurotrophic and apoptotic proteins in the pathogenesis of psychosis via the tPA-BDNF pathway

Yesilkaya U. H., Gica S., Guney Tasdemir B., Ozkara Menekseoglu P., Cirakli Z., KARAMUSTAFALIOĞLU N.

Journal of Psychiatric Research , cilt.142, ss.160-166, 2021 (SCI-Expanded, SSCI, Scopus)

24. Neutrophil-lymphocyte ratio (NLR): a marker beyond inflammation? Comment on PMID: 32174125

Kalelioglu T., Penberthy J. K., KARAMUSTAFALIOĞLU N.

Australasian Psychiatry , cilt.29, sa.5, ss.559, 2021 (SCI-Expanded, SSCI, Scopus)

25. Serum nitric oxide levels are depleted in depressed patients treated with electroconvulsive therapy

ATAGÜN M. İ., Atay O., BALABAN Ö. D., Ipekcioglu D., Alpugan B., Yalcin S., et al.

Indian Journal of Psychiatry , cilt.63, sa.5, ss.456-461, 2021 (SCI-Expanded, SSCI, Scopus)

26. Can neutrophil-lymphocyte ratio be a useful criterion for neuroleptic malignant syndrome in the absence of leukocytosis?

Kalelioglu T., Celikel G., BALABAN Ö. D., KARAMUSTAFALIOĞLU N., Penberthy J. K.

Iranian Journal of Psychiatry , cilt.16, sa.3, ss.370-373, 2021 (Scopus)

27. Electroconvulsive Therapy and Extracellular Matrix Glycoproteins in Patients with Depressive Episodes

Canbek O. A., ATAGÜN M. İ., BALABAN Ö. D., Ipekcioglu D., Alpugan B., Yalcin S., et al.

Psychiatry and Clinical Psychopharmacology , cilt.31, sa.2, ss.157-164, 2021 (SCI-Expanded, Scopus, TRDizin)

28. Antipsychotic-Induced Drug Rash with Eosinophilia and Systemic Symptoms Syndrome: A Case Report

Gica S., Elmaci Z. C., BALABAN Ö. D., KARAMUSTAFALIOĞLU N.

American Journal of Therapeutics , cilt.28, sa.2, 2021 (SCI-Expanded, Scopus)

29. Clozapine-Associated Stuttering: A Case Report

Gıca S., Kılıç C., KARAMUSTAFALIOĞLU N.

American Journal of Therapeutics , cilt.27, sa.6, 2020 (SCI-Expanded, Scopus)

30. Platelet mass index as an indicator of platelet activation in manic episode

Kara A., KARAMUSTAFALIOĞLU N., Kalelioglu T., Genc A., Emul M.

Neurology Psychiatry and Brain Research , cilt.37, ss.1-5, 2020 (Scopus)

31. Resolvin D1 as a novel anti-inflammatory marker in manic, depressive and euthymic states of bipolar disorder

Kok Kendirlioglu B., Unalan Ozpercin P., Yuksel Oksuz O., Sozen S., Cihnioglu R., Kalelioglu T., et al.

Nordic Journal of Psychiatry , cilt.74, sa.2, ss.83-88, 2020 (SCI-Expanded, SSCI, Scopus)

32. Investigating the Impact of the ECT on Thiol-Disulphide Homeostasis in Depressive Disorders

ATAGÜN M. İ., Atay O. C., BALABAN Ö. D., Ipekcioglu D., Alpugan B., Yalcin S., et al.

Psychiatry and Clinical Psychopharmacology , cilt.30, sa.2, ss.1-8, 2020 (SCI-Expanded, Scopus)

33. Serum osmolarity and blood viscosity as a potential explanation for the pathophysiology of neuroleptic malignant syndrome

Kalelioglu T., KARAMUSTAFALIOĞLU N., Celikel G., Genc A., Emul M.

International Journal of Psychiatry in Clinical Practice , cilt.23, sa.4, ss.307-310, 2019 (SCI-Expanded, Scopus)

34. Clinical utility of neutrophil–lymphocyte ratio in the diagnosis of neuroleptic malignant syndrome

KARAMUSTAFALIOĞLU N., Kalelioglu T., Celikel G., Genc A., Emul M.

Nordic Journal of Psychiatry , cilt.73, sa.4-5, ss.288-292, 2019 (SCI-Expanded, SSCI, Scopus)

35. Comparison of the complete blood count-derived infl ammatory markers in bipolar patients with manic and mixed episodes

Kirlioglu S., Balcioglu Y., Kalelioglu T., Erten E., KARAMUSTAFALIOĞLU N.

Bratislava Medical Journal , cilt.120, sa.3, ss.195-199, 2019 (SCI-Expanded, Scopus)

36. A new interpretation of neutrophil-lymphocyte ratio from psychiatric aspect

Kalelioglu T., KARAMUSTAFALIOĞLU N.

Bratislava Medical Journal , cilt.120, sa.8, ss.604-605, 2019 (SCI-Expanded, Scopus)

37. Does blood flow change according to mood? Blood rheology in bipolar disorder

Kalelioglu T., Kocabiyik M., Kok B., Unalan P., Sozen S., Yuksel O., et al.

Clinical Psychopharmacology and Neuroscience , cilt.16, sa.3, ss.310-315, 2018 (SCI-Expanded, Scopus)

38. Comment on “Diabetes mellitus and first episode mania associated with cardiovascular diseases in patients with older-age bipolar disorder”

Kalelioglu T., KARAMUSTAFALIOĞLU N., Genc A., Emul M.

Psychiatry Research , cilt.262, ss.340, 2018 (SCI-Expanded, SSCI, Scopus)

39. Decreased circulating urokinase plasminogen activator receptor (uPAR) concentration in acute episodes of bipolar disorder; could it be a reflection of axonal injury?

Ozpercin P. U., Kendirlioglu B. K., Sozen S., Yuksel O., Cihnioğlu R., Kalelioglu T., et al.

Psychoneuroendocrinology , cilt.90, ss.122-126, 2018 (SCI-Expanded, Scopus)

40. Atherogenic index of plasma as a cardiovascular risk marker in manic, depressive, and euthymic stages of bipolar disorder Bipolar bozukluğun manik, depresif ve ötimik evrelerinde bir kardiyovasküler risk belirleyicisi olarak aterojenik plazma indeksi

Kalelioğlu T., Unalan P., Kök B., Sözen Ş., Yüksel Ö., Akkuş M., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.46, sa.1, ss.32-38, 2018 (Scopus, TRDizin)

41. Assessment of cardiovascular risk via atherogenic indices in patients with bipolar disorder manic episode and alterations with treatment

Kalelioglu T., Genc A., KARAMUSTAFALIOĞLU N., Emul M.

Diabetes and Metabolic Syndrome: Clinical Research and Reviews , cilt.11, 2017 (Scopus)

42. Serum osmolarity in male patients with bipolar disorder manic episode

Kalelioglu T., KARAMUSTAFALIOĞLU N., Genc A., Kocabiyik M.

Experimental Physiology , cilt.102, sa.10, ss.1264-1268, 2017 (SCI-Expanded, Scopus)

43. Serum peroxisome proliferator-activated receptor-gamma levels in acute phase of male patients with schizophrenia and their relationship with metabolic parameters

Kalelioglu T., Durak N., KARAMUSTAFALIOĞLU N., Genc A., Akkus M., Tasdemir A., et al.

Psychiatry and Clinical Psychopharmacology , cilt.27, sa.1, ss.30-34, 2017 (SCI-Expanded, Scopus)

44. Electroconvulsive therapy and oxidative stress: Comment on the article of Şenyurt et al. (Clin Psychophacol Neurosci 2017;15:40-46)

Kalelioglu T., Genc A., KARAMUSTAFALIOĞLU N.

Clinical Psychopharmacology and Neuroscience , cilt.15, sa.3, ss.298-299, 2017 (SCI-Expanded, Scopus)

45. Serum NUCB2/nesfatin-1 levels in different stages of alcohol dependence: Is there a relationship with craving?

UMUT G., Evren C., Cansiz A., Akkus M., KARAMUSTAFALIOĞLU N.

Indian Journal of Psychiatry , cilt.59, sa.1, ss.94-99, 2017 (SCI-Expanded, SSCI, Scopus)

46. Serum soluble urokinase-type plasminogen activator receptor levels in male patients with acute exacerbation of schizophrenia

Genc A., Kalelioglu T., KARAMUSTAFALIOĞLU N., Tasdemir A., Genc E. S., Akkus M., et al.

Psychiatry Research , cilt.236, ss.179-181, 2016 (SCI-Expanded, SSCI, Scopus)

47. Metabolic parameters in patients with major depression treated with escitalopram Essitalopram ile tedavi edilen majör depresyon hastalarında metabolik parametreler

Demirci O. O., Fistikci N., Sağaltici E., KARAMUSTAFALIOĞLU N., Yildirim A., İlnem M. C.

Anadolu Psikiyatri Dergisi , cilt.17, sa.6, ss.482-488, 2016 (SCI-Expanded, Scopus, TRDizin)

48. Acute psychotic attack under isoniazid treatment: A case report

UMUT G., Dernek B., Kucukparlak I., AYDIN T., KARAMUSTAFALIOĞLU N., KESİKTAŞ F. N.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.29, sa.4, ss.379-381, 2016 (Scopus, TRDizin)

49. Neutrophil-lymphocyte and platelet-lymphocyte ratios as inflammation markers for bipolar disorder

Kalelioglu T., Akkus M., KARAMUSTAFALIOĞLU N., Genc A., Genc E. S., Cansiz A., et al.

Psychiatry Research , cilt.228, sa.3, ss.925-927, 2015 (SCI-Expanded, SSCI, Scopus)

50. Plasma BDNFs level initially and post treatment in acute mania: comparison between ECT and atypical antipsychotic treatment and healthy controls

KARAMUSTAFALIOĞLU N., Genc A., Kalelioglu T., Tasdemir A., UMUT G., Incir S., et al.

Journal of Psychopharmacology , cilt.29, sa.8, ss.898-902, 2015 (SCI-Expanded, Scopus)

51. Comparison of propofol, etomidate, and thiopental in anesthesia for electroconvulsive therapy: A randomized, double-blind clinical trial

Canbek O., Ipekcioglu D., Menges O. O., ATAGÜN M. İ., KARAMUSTAFALIOĞLU N., Cetinkaya O. Z., et al.

Journal of ECT , cilt.31, sa.2, ss.91-97, 2015 (SCI-Expanded, SSCI, Scopus)

52. Level of plasma thioredoxin in male patients with manic episode at initial and post-electroconvulsive or antipsychotic treatment

Genc A., Kalelioglu T., KARAMUSTAFALIOĞLU N., Tasdemir A., Gungor F. C., Genc E. S., et al.

Psychiatry and Clinical Neurosciences , cilt.69, sa.6, ss.344-350, 2015 (SCI-Expanded, Scopus)

53. Initial and post-treatment total oxidant-antioxidant status and oxidative stress index in male patients with manic episode

Kalelioglu T., Genc A., KARAMUSTAFALIOĞLU N., Tasdemir A., Can Gungor F., Cansiz A., et al.

Psychiatry Research , cilt.218, sa.1-2, ss.249-251, 2014 (SCI-Expanded, SSCI, Scopus)

54. The relationship of symptoms of anxiety and depression with disease severity and treatment modality in Myasthenia gravis: A cross-sectional study Miyastenia graviste anksiyete ve depresif belirtilerin, hastali{dotless}k şiddeti ve tedavi biçimiyle ilişkisi: Kesitsel bir çali{dotless}şma

Aysal F., KARAMUSTAFALIOĞLU K. O., Özçelik B., Yilmaz M., KARAMUSTAFALIOĞLU N., Yumrukçal H., et al.

Noropsikiyatri Arsivi , cilt.50, sa.4, ss.295-300, 2013 (SCI-Expanded, Scopus, TRDizin)

55. A case report of priapism caused by ziprasidon

KARAMUSTAFALIOĞLU N., Kalelioglu T., TANRIÖVER Ö., Gungor F. C., Genc A., Ilnem C.

Psychiatry Investigation , cilt.10, sa.4, ss.425-427, 2013 (SCI-Expanded, SSCI, Scopus)

56. The case of a 43-year old Turkish male patient with Nasu-Hakola disease

Maner F., Ipekçioǧlu D., KARAMUSTAFALIOĞLU N., Karagöz Sakalli N., Çetinkaya Ö., Ilnem M. C., et al.

Asian Journal of Psychiatry , cilt.6, sa.6, ss.631-632, 2013 (Scopus)

57. The nesfatin 1 level in male patients with manic episode and alterations of nesfatin 1 level after antipsychotic and electroconvulsive treatment

Emul M., KARAMUSTAFALIOĞLU N., Kalelioglu T., Genc A., Tasdemir A., Gungor F. C., et al.

Journal of Affective Disorders , cilt.151, sa.3, ss.849-853, 2013 (SCI-Expanded, SSCI, Scopus)

58. Frequency of cigarette smoking among psychiatric inpatients evaluated by the Fagerström test for nicotine dependence

TANRIÖVER Ö., KARAMUSTAFALIOĞLU N., Tezvaran Z., Kaplan A., Tomruk N.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.1, ss.579-582, 2013 (SCI-Expanded, Scopus)

59. The correlation of suicide attempt and suicidal ideation with insight, depression and severity of illness in schizophrenic patients

UMUT G., Altun Z. O., Danismant B. S., Kucukparlak I., KARAMUSTAFALIOĞLU N., Ilnem M. C.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.26, sa.4, ss.341-350, 2013 (Scopus, TRDizin)

60. Sociodemographic and clinical features of patients with bipolar I disorder in Turkey-HOME study Türkiye'de bipolar i bozukluǧu hastalarının, sosyodemografik ve klinik özellikleri-HOME çalışması

AKKAYA C., Altin M., Kora K., KARAMUSTAFALIOĞLU N., Yaşan A., Tomruk N., et al.

Klinik Psikofarmakoloji Bulteni , cilt.22, sa.1, ss.31-42, 2012 (SCI-Expanded, Scopus, TRDizin)

61. Relationship between treatment adherence, insight and violence among schizophrenia inpatients in a training hospital sample

UMUT G., Altun Z. Ö., Danismant B. S., Küçükparlak I., KARAMUSTAFALIOĞLU N.

Dusunen Adam - The Journal of Psychiatry and Neurological Sciences , cilt.25, sa.3, ss.212-220, 2012 (Scopus, TRDizin)

62. The sociodemographic and clinical characteristics of the psychiatric emergency patients with 60 years or older Bir eǧitim hastanesi psikiyatri acil servisine başvuran yaşlı hastaların sosyodemografik ve klinik özellikleri

Ipekçioǧlu D., Çetinkaya Ö., Küçükparlak I., Güveli H., Bozgeyik G., KÜÇÜKGÖNCÜ S., et al.

Anadolu Psikiyatri Dergisi , cilt.13, sa.1, ss.24-31, 2012 (SCI-Expanded, Scopus, TRDizin)

63. The frequency of metabolic syndrome in schizoprenia patients using antipsychotic medication and related factors Antipsikotik kullanan şizofreni hastalarında metabolik sendrom sıklıǧı ve ilişkili etmenleri

Güveli H., Cem Ilnem M., Yener F., KARAMUSTAFALIOĞLU N., Ipekçioǧlu D., Abanoz Z.

Yeni Symposium , cilt.49, sa.2, ss.67-76, 2011 (Scopus)

64. Olgu sunumları: Neurosyphilis in the differential diagnosis of late onset psychiatric disorders: Case reports Geç başlangıçlı psikiyatrik tabloların ayırıcı tanısında nörosifiliz

Güngör F. C., KARAMUSTAFALIOĞLU N., Genç A., Yener F., Ilnem C.

Klinik Psikofarmakoloji Bulteni , cilt.21, sa.3, ss.258-261, 2011 (SCI-Expanded, Scopus, TRDizin)

65. Predictive factors for time to remission and recurrence in patients treated for acute mania: Health outcomes of manic episodes (HOME) study

Kora K., Saylan M., AKKAYA C., KARAMUSTAFALIOĞLU N., Tomruk N., Yasan A., et al.

Primary Care Companion to the Journal of Clinical Psychiatry , cilt.10, sa.2, ss.114-119, 2008 (Scopus)

66. Tolerability and safety of aripiprazole in schizophrenic patients Şizofreni hastalarinda aripiprazol'ün tolerabilitesi ve güvenirliǧi

KARAMUSTAFALIOĞLU K. O., KARAMUSTAFALIOĞLU N.

Klinik Psikofarmakoloji Bulteni , cilt.18, sa.SUPPL. 1, 2008 (SCI-Expanded, Scopus, TRDizin)

67. Natural course of posttraumatic stress disorder: A 20-month prospective study of Turkish earthquake survivors

KARAMUSTAFALIOĞLU K. O., Zohar J., Güveli M., Gal G., Bakim B., Fostick L., et al.

Journal of Clinical Psychiatry , cilt.67, sa.6, ss.882-889, 2006 (SCI-Expanded, SSCI, Scopus)

68. Phenomenological differences between adolescent and adult onset mania: a comparative study Ergen ve erişkin başlangiçli maninin fenomenolojik farkliliklari: karşilaştirmali bir calişma.

ERKIRAN M., KARAMUSTAFALIOĞLU N., Tomruk N., Kahraman E., Alpay N.

Türk psikiyatri dergisi = Turkish journal of psychiatry , cilt.14, sa.1, ss.21-30, 2003 (Scopus, TRDizin)

69. Obsessive Compulsive Disorder and depression Obsesif Kompulsif Bozukluk ve depresyon

Oǧuz Karamustafalioǧlu X., KARAMUSTAFALIOĞLU N.

Klinik Psikofarmakoloji Bulteni , cilt.10, sa.1, ss.26-31, 2000 (Scopus, TRDizin)

70. Drug treatments in personality disorders Kişilik bozukluklarinda i̇laç tedavileri

KARAMUSTAFALIOĞLU N., KARAMUSTAFALIOĞLU K. O.

Klinik Psikofarmakoloji Bulteni , cilt.10, sa.2, ss.103-108, 2000 (Scopus, TRDizin)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Tez Danışmanlığı

Açık Erişim